Biovalley (833266) was punished for suspected letter disclosure violations. It was the first listed company to be disciplined by the Beijing Stock Exchange. On July 12, 2022, Yunnan Biovalley Pharmaceutical Co., Ltd. (securities abbreviation: Biovalley, stock code: 833266) issued

2024/06/2707:07:33 finance 1628

Bio Valley (833266) was punished for suspected letter disclosure violations. It was the first listed company to be disciplined by the North Exchange

On July 12, 2022, Yunnan Bio Valley Pharmaceutical Co., Ltd. (securities abbreviation: Bio Valley, stock code: 833266) announced that it had received the "Decision on Disciplinary Sanctions on Yunnan Bio Valley Pharmaceutical Co., Ltd. and related responsible entities" ([2022] No. 1) made by Beijing Stock Exchange . This is also the first time that the Beijing Stock Exchange has imposed disciplinary sanctions on a listed company since its opening.

It has been found that Bio Valley has the following illegal activities:

(1) Occupation of funds

From November 2021 to January 2022, the company endorsed bank acceptance bills to third-party institutions, and the endorsement transfer was not returned to the company. , the controlling shareholder admitted that the endorsement transfer money was transferred to Jinshajiang, and Jinshajiang occupied a total of 78.7644 million yuan of company funds through this method. From December 2021 to January 2022, the endorsed party has re-endorsed the note back to the company, and the occupied funds have been returned through the above methods. Starting from August 2021, the company entrusted Yinfengtai Fund Management Co., Ltd. with financial management funds of 265 million yuan, and entrusted Guoshen Financial Leasing (Yunnan) Co., Ltd. with financial management funds of 12 million yuan. Subsequently, the above financial management funds were transferred to Jinshajiang and its related parties and controlling shareholders believe that they will ultimately be used by Jinshajiang to repay debts and make industrial investments. The above-mentioned actions constituted misappropriation of funds, occupying 277 million yuan of company funds.

(2) Information disclosure violations

On November 5, 2021, the company entrusted Yinfengtai Fund Management Co., Ltd. with a cumulative financial management amount of 110 million yuan. The company failed to perform its information disclosure obligations in a timely manner as required, and it also failed to fulfill its information disclosure obligations for subsequent financial management purchases. . The company made additional disclosures in the "2021 Annual Report" and "The Board of Directors' Self-examination Report and Rectification Plan on the Occupation of Non-Operating Funds by Related Parties of Controlling Shareholders" on April 29, 2022.

(3) Unfulfilled promises

In response to the aforementioned fund occupation facts, the controlling shareholder Jinshajiang and the actual controller Lin Yanhe promised: Jinshajiang will return all occupied funds and capital gains before June 30, 2022, and the company’s actual controller Lin Yanhe Yanhe promises to provide joint liability guarantee. As of June 30, 2022, Jinshajiang has only returned 10 million yuan to the company, and the above commitments have not been fully fulfilled.

Lawyer Wang Jinlong from Shanghai Chuanhui Law Firm said that based on the illegal facts discovered by the Beijing Stock Exchange on Biovalley and the judicial interpretation of certain provisions of the Securities Law and the Supreme Court on false statements, Biovalley is suspected of civil infringement, and its implementation There is a causal relationship between the misrepresentation and the losses suffered by shareholders when buying and selling stocks, and they should bear civil liability for compensation according to law. The injured shareholders can claim for loss reduction by filing a lawsuit in court.

Bio Valley claim conditions: Lawyer Wang Jinlong believes that judging from the content of the disciplinary sanctions imposed by the Beijing Stock Exchange on Bio Valley, in accordance with the relevant provisions of the Securities Law and the judicial interpretation of the infringement of securities misrepresentation, is tentatively scheduled for August 27, 2021 Investors who bought Biovalley shares between April 29, 2022, and sold or still held the shares after April 29, 2022, can file a claim.

Shareholder friends can also follow Sina Weibo " Shanghai Lawyer Wang Jinlong " or search and follow the WeChat public account " Shanghai Lawyer Wang Jinlong ". Lawyer Wang Jinlong will promptly release stock claim announcements and case progress through the above platforms so that you can obtain them in time. Latest stock claims information.

Claim litigation materials that need to be prepared:

1. Securities account inquiry confirmation form stamped with the seal of the securities company’s business department and the original stock transaction statement (from the first purchase of the stock to the present);

Special note: the statement needs to have the name and identity of the shareholder Certificate number, securities account number, capital account number, securities code, stock purchase and sale time, transaction price, transaction quantity, etc. If the stock is currently held, a list of treasury stocks needs to be printed.If there are a lot of sales and purchases, in addition to the paper version, please also provide the EXCEL electronic version of the transaction records.

2. Copy of ID card;

3. Relevant prosecution signature materials.

After confirming with Lawyer Wang Jinlong that you meet the claim conditions, Lawyer Wang will send you the claim materials. You only need to prepare the materials as required. After the investor completes the entrustment procedures, the claim will be fully handed over to the lawyer. Legal procedures such as case filing, mediation, and court hearings do not require the investor to go to the court in person. They only need to wait patiently. If there is any progress in the case, the lawyer will be there at the first opportunity. Time to tell. We adopt a contingency fee model. There is no need to pay attorney fees in the early stage. After the investor wins the case and successfully receives compensation, attorney fees will be charged according to a certain proportion of the compensation amount.

Submit materials:

After the above litigation materials are ready, you can come to the law firm to submit them or submit them by mail. The contact information of lawyer Wang Jinlong is as follows:

Address: Room 1405, Jincheng Building, No. 511 Tianmu West Road, Jing'an District, Shanghai

Unit: Shanghai Chuanhui Law Firm

Biovalley (833266) was punished for suspected letter disclosure violations. It was the first listed company to be disciplined by the Beijing Stock Exchange. On July 12, 2022, Yunnan Biovalley Pharmaceutical Co., Ltd. (securities abbreviation: Biovalley, stock code: 833266) issued - DayDayNews

finance Category Latest News